Previous works identified that CD44 is an E-selectin ligand on several different types of cells, such as HSPCs, neutrophils, mouse Th1 cells, breast cancer cells, colon carcinoma cells, and melanoma (24, 26, 28, 29, 41, 56). This evidence concerns the gene CD44 and melanoma.